Skip to main content

A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management

Effects of HQK-1001 in Patients With Sickle Cell Disease

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Effects of HQK-1001 in Patients With Sickle Cell Disease

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 66
  • Page 67
  • Page 68
  • Page 69
  • Page 70
  • Page 71
  • Page 72
  • Page 73
  • Page 74
  • …
  • Next page Next
  • Last page Last
Subscribe to